Login / Signup

Virus-like particles coexpressing the PreF and Gt antigens of respiratory syncytial virus confer protection in mice.

Ki-Back ChuSu-Hwa LeeMin-Ju KimAh-Ra KimEun-Kyung MoonFu-Shi Quan
Published in: Nanomedicine (London, England) (2022)
Aims: The purpose of this study was to assess the protective efficacy of virus-like particles (VLPs) co-expressing the pre-fusogenic (PreF) and G protein with tandem repeats (Gt) antigens of respiratory syncytial virus (RSV) in mice. Materials & methods: VLP constructs expressing PreF, Gt or both were used to immunize mice, and the protective efficacies were evaluated using antibody responses, neutralizing antibody titers, T-cell responses, histopathological assessment and plaque assay. Results: PreF+Gt VLP immunization elicited strong RSV-specific antibody responses and pulmonary T-cell responses that contributed to lessening virus titer and inflammation. Conclusion: Our findings suggest that coexpressing PreF and Gt antigens elicits better protection than either one alone. This combinatorial approach could assist in future RSV vaccine development.
Keyphrases